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ABSTRACTS0374: DOES SOCIO-ECONOMIC STATUS INFLUENCE AMPUTATION
OUTCOMES?
Risha Gohil, Rachel Barnes, Ian Chetter. Hull York Medical School, University
of Hull, Hull Royal Inﬁrmary, Hull & E Yorkshire Hospital Trust, Hull, UK
Aims: To analyse the effect of socioeconomic deprivation on amputation
outcome.Currently 5,000 leg amputations occur annually in England and
Wales and have a 50% mortality rate at 2 years.
Methods: All patients undergoing major lower limb amputation from
January 2005 to December 2009 were identiﬁed from a prospectively
maintained vascular database. Patient's postcodes were used to determine
socioeconomic status using the ACORN classiﬁcation system (1 highest
group to 5 lowest). Non parametric analysis of data was performed using
SPSS version 19.
Results:We identiﬁed354patients (218men;65.5%),medianage68 (IQR58-
78) years. 47 (14.8%) patients were ACORN grade 1, 4 (1.3%) were grade 2, 65
(20.4%) were grade 3, 56(17.6%) were grade 4 and 146 (45.9%) were grade 5.
Signiﬁcant differences were noted for the cardiovascular risk factors;
hyper-cholesterolaemia (p¼0.034), diabetes (p¼0.020), smoking status
(p¼0.006). No signiﬁcant differences were noted between classes for
gender, type of admission (emergency or elective) or mortality (peri-
operative or 1 year death rate) or blood test (haemoglobin, white cells,
urea, creatinine, sodium and potassium).
Conclusions: Socio-economic status of amputees does not have an effect
on mortality. However, their status does impact on their cardiovascular
risk factors, therefore aggressive modiﬁcation remains imperative.
0414: ASSOCIATION OF ANAEMIA IN PATIENTS WITH DIABETIC FOOT
DISEASE
Mustafa Khanbhai, Stavros Loukogeorgakis, Steven Hurel, Richards
Toby. University College London, London, UK
Aims: Anaemia and inﬂammation have been shown to play a role in dia-
betic foot disease. We aim to explore the association between anaemia and
inﬂammation, particularly with stage of diabetic foot disease.
Methods: 175 patients with diabetic foot disease were studied retro-
spectively. Patients were stratiﬁed in groups according to severity of dia-
betic foot disease according to NICE guidelines; D1 to D4, the lowest risk
assigned; D1. Correlation with baseline haemoglobin, C-reactive protein
(CRP) and creatinine was evaluated. Longitudinal analysis of stage of dia-
betic foot disease was analysed.
Results: Haemoglobin was 13.2, 12.3, 11.0 and 9.3 and CRP was 6.1, 22.8,
32.4 and 39.5 in patients stratiﬁed to group D1, D2, D3 and D4 respectively
(P<0.0001). There was an inverse correlation between haemoglobin with
CRP (p<0.001). Equally, evaluation of disease progression demonstrated
that as the diabetic foot deteriorates (D1 vs. D4), haemoglobin declines
(13.4 vs. 9.2) and CRP rises (7.6 vs. 41.2) (P<0.0001). No difference was
found comparing creatinine levels to disease stage. There was no corre-
lation between haemoglobin and creatinine.
Conclusions: Anaemia and inﬂammation are associated with diabetic foot
disease stage. Anaemia was found to be independent of renal function
which may be explained by an underlying inﬂammatory process.
0518: GIANT CELL ARTERITIS; REDEFINING THE ROLE OF TEMPORAL
ARTERY BIOPSY (TAB)
Ashraf Hassouna, Amina Khan, Adnan Qureshi, Avtar Brar. Vascular
department Kettering General Hospital, Kettering, UK
Purpose: TAB remains the deﬁnitive diagnostic test for giant cell arteritis,
although its usefulness is often questioned. However given the morbidity
of both the arteritis and longterm corticosteroid use, TAB may still be
beneﬁcial. We have reviewed our experiences with TAB to redeﬁne its
indications.
Methods:Between2004and2011, 98patientsunderwentTAB.Weevaluated
their demographics, histological ﬁndings and post-operative outcomes.
Results: There were 28 males and 70 females aged between 18 to 92 years.
All biopsies were performed under local anaesthetic with positive histo-
logical ﬁndings in 17% (16/98) cases. Inﬂammatory marker, ESR was
signiﬁcantly raised in positive biopsies (P<0.01), with a sensitivity of 100%
and speciﬁcity of 81%. Furthermore raised inﬂammatory markers and
strong clinical symptoms were seen in 100% positive biopsies compared
with 27% (22/82) negative ones. Out of these 22 patients, 77% had been onsteroid suggesting that steroid treatment may have masked 20% (17/82) of
the results in the negative group. The size of biopsy specimen did not alter
histological outcome. The biopsy result inﬂuenced the subsequent
management in 5% cases.
Conclusions: We found that while TAB is helpful in some patients, more
diagnostic importance should be given to biochemical and clinical
parameters.
0534: AORTODUODENAL FISTULAE FOLLOWING ENDOVASCULAR
ABDOMINAL AORTIC ANEURYSM REPAIR
Athanasios Saratzis 1, Trifonas Papettas 1, Dimitrios Kiskinis 2. 1Coventry
University Hospital, Coventry, UK; 2Aristotle University of Thessaloniki,
Thessaloniki, Greece
Aim: Aortoduodenal ﬁstula (ADF) following endovascular abdominal
aortic aneurysm (EVAR) repair is an exceedingly rare complication as there
is no contact between the duodenum and the endograft. The aim of this
study is to report an 8 year experience with ADF following elective EVAR.
Methods: Our prospective registry of elective EVAR (January 2004 - 2012,
1283 patients) was assessed to identify patients who developed an ADF.
Results: Six patients (all men; mean age 68.8 years, range 60-75) devel-
oped an ADF 18 days to 2 years after successful EVAR. Haematemesis and
abdominal pain were the main presenting symptoms. Contrast computed
tomography (CTA) conﬁrmed the diagnosis in all cases. Graft infection was
the aetiology in 3 patients, 2 ADFs developed due to a type 1A endoleak, no
cause has been identiﬁed in 1 case. All explanted grafts were macro-
scopically intact. All patients underwent emergency surgical exploration.
Three patients died within 24 hours and 3 are well after 3 to 5 years.
Conclusion: This is the largest case-series of ADF following EVAR to date.
ADF is a rare but dangerous complication of EVAR, secondary to infection
or endoleak. Prompt diagnosis and intervention are crucial to avoid a fatal
outcome.
0550: THE FATE OF PATIENTS REFERRED TO A SPECIALISTVASCULAR
UNIT WITH LARGE INFRA-RENAL ABDOMINALAORTIC ANEURYSMS
OVER A TWO-YEAR PERIOD
Nida Pasha 1, Sharanya Kumar 1, Alan Karthikesalingam2, Zaki Akhtar 1,
T Nicoli 2, Peter Holt 2, Robert Hinchliffe 2, Ian Loftus 2, Matt
Thompson 2. 1 St Georges, University of London, London, UK; 2 St Georges
Vascular Institute, London, UK
Introduction: The basic premise in managing patients with abdominal
aortic aneurysms(AAA) must be to reduce overall mortality from the
disease. Operative mortality is widely reported, but data on patients
deemed unsuitable for repair are scarce. The purpose of the present study
was to report the fate of patients referred with AAA, to deﬁne the
proportion deemed unsuitable for surgery and to investigate the reasons
for conservative treatment.
Methods: All patients whowere referred to a regional vascular centre with
large (>5.5cm) infra-renal AAA between 1st January 2008 and 31st
December 2009 were included. Patients were classiﬁed into two groups;
those managed non-operatively, or those offered elective repair. Survival
was reported by Kaplane Meier analysis. Multivariate analysis investigated
factors leading to non-operative management.
Results: 251 patients with a mean (SD) age of 75(8) years were assessed.
Thirty-two(13%) patients were deemed unsuitable for repair, mostly
because of medical co-morbidity (16/32). 219/251(87%) patients under-
went repair(25/251(10%) open repair 194/251(77%) EVAR)with 1/219(0.5%)
30-day mortality. AAA repair was associated with signiﬁcantly greater
survival (p<0.001,log-rank test) at 2years. In multivariate analysis Glasgow
Aneurysm Score, female gender and respiratory disease were signiﬁcant
predictors of the decision to treat patients conservatively(p< 0.001).
Conclusion:Most patients were suitable for surgical interventionwith low
perioperative mortality. Data on "turndown" rates should be routinely
reported to quantify the denominator for operative success.
0593: MULTI-LEVEL BYPASS GRAFTING – IS IT WORTH IT?
Alistair Sharples, Mark Kay, Anthony Fox, Tim Sykes, Andrew
Houghton. Shrewsbury and Telford NHS Trust, Shrewsbury, UK
Traditionally multi-level arterial disease has been treated with an inﬂow
procedure only but simultaneous multi-level bypass graft procedures have
